AS1411 Aptamer-Conjugated Liposomal siRNA Targeting MTA2 Suppresses PI3K/AKT Signaling in Pancreatic Cancer Cells. [PDF]
Kwak M, Hua TC, Jin H, Lee J, Kim DE.
europepmc +1 more source
DNA Nanotechnology-Enabled Precise Regulation of Nanozymes and Their Applications. [PDF]
Liu Z +11 more
europepmc +1 more source
Synthetic short RNA in cancer. [PDF]
Tomita T, Minagawa K, Hiratsuka S.
europepmc +1 more source
Programmable DNAzyme nanocatalysts orchestrate redox-immune coupling for time-gated cancer immunomodulation. [PDF]
Wang L +8 more
europepmc +1 more source
Dual-Mode Aptamer AP1-F Achieves Molecular-Morphological Precision in Cancer Diagnostics via Membrane NCL Targeting. [PDF]
Yang Z, Wang L, Xiao C, Shen X.
europepmc +1 more source
Nucleolin perturbation alters membrane lipid homeostasis.
Zahavi EE +14 more
europepmc +1 more source
The emerging role of aptamers in targeted cancer immunotherapy. [PDF]
Zhu S +7 more
europepmc +1 more source
Aptamer-Nanoconjugates as Potential Theranostics in Major Neuro-Oncological and Neurodegenerative Disorders. [PDF]
Tauser RG +8 more
europepmc +1 more source
Innovative Applications of Nucleic Acid Aptamers in Colorectal Cancer Diagnosis and Therapy: From Selection Optimization to Clinical Translation. [PDF]
Lu JF +7 more
europepmc +1 more source
[Ultrasound-synergized targeted nanoparticles suppress proliferation, migration and invasion of hypoxic lung cancer cells <i>in vitro</i>]. [PDF]
Dong J, Guo J, Li D, DU Y.
europepmc +1 more source

